News and press releases

EMA starts review of Ixchiq (live attenuated chikungunya vaccine)

EMA’s safety committee (PRAC) has started a review of Ixchiq (a live attenuated chikungunya vaccine) following reports of serious adverse events in elderly people.Many of the…

May 7, 2025 - 13:25
 0
EMA starts review of Ixchiq (live attenuated chikungunya vaccine)
EMA’s safety committee (PRAC) has started a review of Ixchiq (a live attenuated chikungunya vaccine) following reports of serious adverse events in elderly people.Many of the…
Read More

Tags:

Previous Article

Your Essential Lithium Battery Recycling Guide 2025: What You MUST Know Now!

Next Article

Referral: Ixchiq, Chikungunya vaccine (live) Article 20 procedures Procedure sta...

Related Posts

Clinical Trials Information System designated as WHO primary registry

Clinical Trials Information System designated as WHO pr...

Apr 26, 2025  0

Leveraging the power of data for public and animal health

Leveraging the power of data for public and animal health

May 7, 2025  0

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-9 April 2025

Meeting highlights from the Committee for Veterinary Me...

Apr 26, 2025  0